Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Hyoscine hydrobromide may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
this medicine
PIL1863
Check the foil is not broken before use. If it is, do not take that tablet. Chew or swallow the first tablet (or part tablet) twenty minutes before your journey begins.
Information for the user
Travel Calm Tablets
Age
How many to take Adults and One tablet children of 12 years and over Children of Half a 7 to 11 tablet years
(Hyoscine Hydrobromide) This medicine is available without prescription • If you have heart failure, or a fast heart beat to treat minor conditions. However, you still • If you have kidney or liver problems need to take it carefully to get the best results • If you have an overactive thyroid from it.
doctor:
200 mm
200 mm
Read all of this leaflet carefully because it contains important information for you.
Children of Quarter of a tablet 3 to 6 years
How often to take it Every 6 to 8 hours, if you need to. Don't take more than 3 tablets in 24 hours. Every 6 to 8 hours, if you need to. Don't give more than 3 half tablets in 24 hours. Every 6 to 8 hours, if you need to. Don't give more than 3 quarter tablets in 24 hours.
Do not give to children under 3 years. Do not take more than the amount recommended above. If you take too many tablets: Talk to your doctor or go to your nearest hospital casualty department. Take the medicine and this leaflet with you.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or by searching for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Leaflet prepared June 2024 Most people will not have problems, but some If you would like any further information about may get some of these: this medicine, please contact
this medicine
Keep this medicine in a safe place out of the sight and reach of children, preferably in a locked cupboard. Use by the date on the end flap of the carton. Do not store above 30°C.
What is in this medicine
Each tablet contains Hyoscine Hydrobromide 0.3 mg, which is the active ingredient. As well as the active ingredient, the tablets also contain glucose, stearic acid, magnesium stearate. The pack contains 12 round white tablets. The tablets are scored on one side into a cross shape so that it can be broken into quarters.
Who makes this medicine
Manufactured for the Marketing Authorisation holder The Boots Company PLC Nottingham NG2 3AA by Bristol Laboratories Ltd Northbridge Road Berkhamsted Herts HP4 1EG
Boots Travel Calm Tablets comes as tablet. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Boots Travel Calm Tablets is hyoscine hydrobromide.
This leaflet reproduces the patient information leaflet approved for Boots Travel Calm Tablets, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the prevention and relief of travel sickness.
Adults and children over 12 years: One tablet.
Children 7 to 12 years: Half a tablet.
Children 3 to 7 years: Quarter of a tablet.
Not to be taken by children under 3 years.
Elderly: The normal adult dose is still appropriate in the elderly.
The dose should be taken 20 minutes before the journey and may be repeated in 6-8 hours if necessary.
Not more than three doses to be taken in 24 hours.
For oral administration.
Prostatic enlargement, paralytic ileus, pyloric stenosis, closed angle glaucoma.
Should be used with caution in conditions characterised by tachycardia such as thyrotoxicosis and cardiac failure. Should be used with caution by elderly patients and in patients suffering from impaired renal, hepatic or metabolic function.
Warning: May cause drowsiness. If affected do not drive or operate machinery. Avoid alcoholic drink.
There have been rare reports of an increase in frequency of seizures in epileptic patients.
Not more than three doses to be taken in 24 hours.
Keep all medicines out of the reach of children.
This medicine contains dextrose monohydrate, also known as glucose. Patients with rare glucose-galactose malabsorption should not take this medicine.
The effects of hyoscine may be enhanced by other drugs with anticholinergic properties, including amantadine, some antihistamines, butyrophenones, phenothiazines and tricyclic antidepressants. Patients should also avoid alcohol. The reduction in gastric motility caused by hyoscine may also affect the absorption of other drugs.
The safety of hyoscine during pregnancy and lactation has not been established, although there is no definite evidence of adverse consequences if taken during early pregnancy. No significant quantities of hyoscine were found in milk when the drug was given to lactating women. Nevertheless, the product should not be used during pregnancy, unless the expected benefit is thought to outweigh any possible risk to the foetus.
Hyoscine may cause drowsiness and dulling of mental alertness and therefore those taking this medication should not take charge of motor vehicles or operate machinery.
Side effects may include drowsiness, dryness of the mouth, thirst, reduced bronchial secretions, mydriasis, loss of accommodation, photophobia, increased intra-ocular pressure, flushing, dry skin, bradycardia followed by tachycardia, with palpitations and arrhythmias, difficulty in micturition, reduction in tone and motility of the gastrointestinal tract leading to constipation. Occasionally vomiting, giddiness and staggering may occur. There have also been occasional reports of confused states and hallucinations when given to children.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or by searching for MHRA Yellow Card in the Google Play or Apple App Store.
Symptoms of overdosage may include any of the undesirable effects mentioned above under section 4.8 and tachycardia, rapid or stertorous respiration, hyperpyrexia, restlessness, confusion and excitement, hallucinations and delirium. In severe cases, depression of the central nervous system may occur with coma, circulatory and respiratory failure and death.
Treatment consists of emptying the stomach by lavage and aspiration. Charcoal may be used to prevent further absorption. Give a saline purgative, such as sodium sulphate 30g in 250ml of water.
Peripheral anticholinergic effects may be controlled by the administration of the antichlolinesterase, neostigmine. Excitement may be controlled by diazepam. Otherwise treatment should be symptomatic and supportive.
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Not the same combination. This medicine contains Hyoscine hydrobromide. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Boots Travel Calm Tablets. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.